{"transactions":[{"id":697763,"issuer":{"id":7783,"kind":"organization","name":"Inhibitor Therapeutics, Inc."},"owners":[{"id":26794,"kind":"person","name":"SEARS SAMUEL P JR","position":1,"cik":"0001238483","reported_name":"SEARS SAMUEL P JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-04T16:15:19.000Z","date":"2026-05-04","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted common stock issued to the Reporting Person as compensation pursuant to the Issuer's 2025 Equity Incentive Plan, subject to shareholder approval."}],"balance_after":1229543,"source":{"system":"sec-edgar","filing":"0001493152-26-035953","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1042418/000149315226035953/ownership.xml","form_type":"4"}},{"id":1176941,"issuer":{"id":7783,"kind":"organization","name":"Inhibitor Therapeutics, Inc."},"owners":[{"id":26794,"kind":"person","name":"SEARS SAMUEL P JR","position":1,"cik":"0001238483","reported_name":"SEARS SAMUEL P JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-07T21:23:08.000Z","date":"2025-04-01","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted common stock issued to the Reporting Person as compensation pursuant to the Issuer's 2014 Equity Incentive Plan."}],"balance_after":1279543,"source":{"system":"sec-edgar","filing":"0001641172-25-003029","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1042418/000164117225003029/ownership.xml","form_type":"4"}},{"id":1514707,"issuer":{"id":7783,"kind":"organization","name":"Inhibitor Therapeutics, Inc."},"owners":[{"id":26794,"kind":"person","name":"SEARS SAMUEL P JR","position":1,"cik":"0001238483","reported_name":"SEARS SAMUEL P JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-16T17:34:35.000Z","date":"2024-04-01","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted common stock issued to the Reporting Person as compensation pursuant to the Issuer's 2014 Equity Incentive Plan."}],"balance_after":1129543,"source":{"system":"sec-edgar","filing":"0001493152-24-020173","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1042418/000149315224020173/ownership.xml","form_type":"4"}},{"id":4158580,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26794,"kind":"person","name":"SEARS SAMUEL P JR","position":1,"cik":"0001238483","reported_name":"SEARS SAMUEL P JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-11-17T17:00:25.000Z","date":"2017-11-15","kind":"sale","acquired":false,"shares":12000,"price":2.25,"value":27000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares of Issuer's Common Stock were sold pursuant to a pre-planned 10b5-1 plan to cover the Reporting Person's tax liability upon the vesting of RSUs in August 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On November 15, 2017, the Reporting Person sold an aggregate of 12,000 shares of the Issuer's Common Stock at a weighted average price of $2.25 per share. The highest sale price for the Common Stock was $2.35 per share and the lowest sale price was $2.15 per share. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":82863,"source":{"system":"sec-edgar","filing":"0000899243-17-026806","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000089924317026806/doc4.xml","form_type":"4"}},{"id":4232741,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26794,"kind":"person","name":"SEARS SAMUEL P JR","position":1,"cik":"0001238483","reported_name":"SEARS SAMUEL P JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-08-16T18:02:11.000Z","date":"2017-08-14","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of one-half of the RSUs granted to the Reporting Person on July 14, 2017 under the Issuer's 2011 Equity Incentive Plan, as amended. The remaining RSUs under this grant will vest in the first open window following the Company's 2018 Annual Meeting of Stockholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of one-half of the RSUs granted to the Reporting Person on July 14, 2017 under the Issuer's 2011 Equity Incentive Plan, as amended. The remaining RSUs under this grant will vest in the first open window following the Company's 2018 Annual Meeting of Stockholders."}],"balance_after":15000,"derivative":{"exercise_price":0,"exercise_date":"2017-08-14","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000899243-17-020518","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000089924317020518/doc4.xml","form_type":"4"}},{"id":4232740,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26794,"kind":"person","name":"SEARS SAMUEL P JR","position":1,"cik":"0001238483","reported_name":"SEARS SAMUEL P JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-08-16T18:02:11.000Z","date":"2017-08-14","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of 15,000 Restricted Stock Units (\"RSUs\") granted to the Reporting Person on June 30, 2016 under the Issuer's 2011 Equity Incentive Plan, as amended."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2017-08-14","expiration_date":"2017-08-14","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000899243-17-020518","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000089924317020518/doc4.xml","form_type":"4"}},{"id":4232739,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26794,"kind":"person","name":"SEARS SAMUEL P JR","position":1,"cik":"0001238483","reported_name":"SEARS SAMUEL P JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-08-16T18:02:11.000Z","date":"2017-08-14","kind":"exercise","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of one-half of the RSUs granted to the Reporting Person on July 14, 2017 under the Issuer's 2011 Equity Incentive Plan, as amended. The remaining RSUs under this grant will vest in the first open window following the Company's 2018 Annual Meeting of Stockholders."}],"balance_after":94863,"source":{"system":"sec-edgar","filing":"0000899243-17-020518","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000089924317020518/doc4.xml","form_type":"4"}},{"id":4232738,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26794,"kind":"person","name":"SEARS SAMUEL P JR","position":1,"cik":"0001238483","reported_name":"SEARS SAMUEL P JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-08-16T18:02:11.000Z","date":"2017-08-14","kind":"exercise","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of 15,000 Restricted Stock Units (\"RSUs\") granted to the Reporting Person on June 30, 2016 under the Issuer's 2011 Equity Incentive Plan, as amended."}],"balance_after":79863,"source":{"system":"sec-edgar","filing":"0000899243-17-020518","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000089924317020518/doc4.xml","form_type":"4"}},{"id":4255461,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26794,"kind":"person","name":"SEARS SAMUEL P JR","position":1,"cik":"0001238483","reported_name":"SEARS SAMUEL P JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2017-07-18T16:01:22.000Z","date":"2017-07-14","kind":"grant","acquired":true,"shares":15000,"price":2.64,"value":39600.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options (\"options\") were issued to the Reporting Person on July 14, 2017, as compensation for service on the Issuer's board of directors. The options vest as follows: (i) 7,500 RSUs vest in the first open window following the filing of Company's quarterly 10Q for June 30, 2017 and (b) 7,500 RSUs vest in the first open window following the Company's 2018 Annual Meeting of Stockholders."}],"balance_after":15000,"derivative":{"exercise_price":2.64,"expiration_date":"2027-07-14","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000899243-17-018424","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000089924317018424/doc4.xml","form_type":"4"}},{"id":4255460,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26794,"kind":"person","name":"SEARS SAMUEL P JR","position":1,"cik":"0001238483","reported_name":"SEARS SAMUEL P JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-07-18T16:01:22.000Z","date":"2017-07-14","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units (\"RSUs\") were issued to the Reporting Person on July 14, 2017, as compensation for service on the Issuer's board of directors. The RSUs vest as follows: (i) 15,000 RSUs vest in the first open window following the filing of the Company's quarterly 10Q for June 30, 2017 and (b) 15,000 RSUs vest in the first open window following the Company's 2018 Annual Meeting of Stockholders."}],"balance_after":30000,"derivative":{"exercise_price":0,"expiration_date":"2018-08-13","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000899243-17-018424","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000089924317018424/doc4.xml","form_type":"4"}},{"id":4535628,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26794,"kind":"person","name":"SEARS SAMUEL P JR","position":1,"cik":"0001238483","reported_name":"SEARS SAMUEL P JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-12-02T18:00:29.000Z","date":"2016-12-01","kind":"sale","acquired":false,"shares":12000,"price":1.67,"value":20040.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares of Issuer's Common Stock were sold pursuant to a pre-planned 10b5-1 plan to cover the Reporting Person's tax liability upon the vesting of RSUs in August 2016."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On December 1, 2016, the Reporting Person sold an aggregate of 12,000 shares of the Issuer's Common Stock at a weighted average price of $1.67 per share. The highest sale price for the Common Stock was $1.75 per share and the lowest sale price was $1.60 per share. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The Form 4 filed on August 12, 2016 inadvertently excluded 1,000 shares held by the Reporting Person."}],"balance_after":64863,"source":{"system":"sec-edgar","filing":"0000899243-16-034863","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000089924316034863/doc4.xml","form_type":"4"}}]}